EMEA-001555-PIP01-13-M04 - paediatric investigation plan
eravacycline
PIPHuman
PAION Deutschland GmbH
Tel. +49 241 4453 0
E-mail: reg_paion@paion.com
P/0255/2020 : EMA decision of 15 July 2020 on the acceptance of a modification of an agreed paediatric investigation plan for Eravacycline (Xerava) (EMEA-001555-PIP01-13-M04)